Extra villous trophoblast-derived PDL1 can ameliorate macrophage inflammation and promote immune adaptation associated with preeclampsia
Journal of Reproductive Immunology · 2024
DOI: 10.1016/j.jri.2023.104186 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Reproductive Immunology, 2024. Verfasst von Yutong Cui und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department Obstetrics, Obstetrics and Gynaecology Hospital of Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Pre-Eclampsia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Severe preeclampsia (sPE) is a systemic syndrome that may originate from chronic inflammation. Maintaining maternal-fetal hemostasis by the co-inhibitory molecule programmed death ligand 1 (PDL1) can be favorable for ameliorating inflammation from immune cells. Apart from programmed death 1 (PD1) expression, decidual macrophages (dMs) produce inflammatory cytokines, in response to cells which express PDL1. However, strong evidence is lacking regarding whether the PDL1/PD1 interaction between trophoblasts and decidual macrophages affects inflammation during sPE development. METHODS: To determine whether the trophoblast-macrophage crosstalk via the PDL1/PD1 axis modulates the inflammatory response in sPE-like conditions, at first, maternal-fetal tissues from sPE and normal patients were collected, and the PDL1/PD1 distribution was analyzed by Western blot, immunohistochemistry/ immunofluorescence and flow cytometry. Next, a coculture system was established and flow cytometry was used to identify how PDL1 was involved in macrophage-related inflammation under hypoxic stress. Transcriptional analysis was performed to clarify the inflammation-associated pathway induced by the PDL1/PD1 interaction. Finally, the Nω-nitro-L-arginine methyl ester hydrochloride (L-NAME) mouse model was used to examine the effect of PDL1 on macrophage-related inflammation by measuring PE-like symptoms. RESULTS: In maternal-fetal tissue from sPE patients, placental extravillous trophoblasts (EVTs) and dMs had a surprisingly increase of PDL1 and PD1 expression, respectively, accompanied by a higher percentage of CD68 +CD86 + dMs. In vitro experiments showed that trophoblast-derived PDL1 under hypoxia interacted with PD1 on CD14 +CD80 +macrophages, leading to suppression of inflammation through the TNFα-p38/NFκB pathway. Accordingly, the PE-like mouse model showed a reversal of PE-like symptoms and a reduced F4/80 + CD86 + macrophage percentage in the uterus in response to recombinant PDL1 protein administration, indicating the protective effect of PDL1. DISCUSSION: Our results initially explained an immunological adaptation of trophoblasts under placental hypoxia, although this protection was insufficient. Our findings suggest the possible capacity of modulating PDL1 expression as a potential therapeutic strategy to target the inflammatory response in sPE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department Obstetrics, Obstetrics and Gynaecology Hospital of Fudan University, Shanghai, China.
- Department of Obstetrics, Shenzhen Maternity and Child Healthcare Hospital, Shenzhen, Guangdong, China.
- Department Obstetrics, Obstetrics and Gynaecology Hospital of Fudan University, Shanghai, China; Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Fudan University, Shanghai, China. Electronic a…
- Department Obstetrics, Obstetrics and Gynaecology Hospital of Fudan University, Shanghai, China; Department of Obstetrics, Shenzhen Maternity and Child Healthcare Hospital, Shenzhen, Guangdong, China. Electronic address…
Zitieren
APA
Cui, Y., Wu, S., Liu, K., Zhao, H., Ma, B., Gong, L., Zhou, Q., & Li, X. (2024). Extra villous trophoblast-derived PDL1 can ameliorate macrophage inflammation and promote immune adaptation associated with preeclampsia. Journal of Reproductive Immunology. https://doi.org/10.1016/j.jri.2023.104186
Vancouver
Cui Y, Wu S, Liu K, Zhao H, Ma B, Gong L, et al. Extra villous trophoblast-derived PDL1 can ameliorate macrophage inflammation and promote immune adaptation associated with preeclampsia. Journal of Reproductive Immunology. 2024. doi:10.1016/j.jri.2023.104186
BibTeX
@article{Cui2024,
author = {Cui, Yutong and Wu, Suwen and Liu, Ketong and Zhao, Huanqiang and Ma, Bo and Gong, Lili and Zhou, Qiongjie and Li, Xiaotian},
title = {Extra villous trophoblast-derived PDL1 can ameliorate macrophage inflammation and promote immune adaptation associated with preeclampsia},
journal = {Journal of Reproductive Immunology},
year = {2024},
doi = {10.1016/j.jri.2023.104186}
}
EUVIMED